Jacobson Allan Steven sold PTCT
November 24, 2025 · Form 4 insider transaction
Jacobson Allan Steven sold 6,100 shares of PTC Therapeutics, Inc. at $80.15 per share, a transaction worth $488.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 12, 2025; This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.